Exiqon
Home Search Contact Print Mobile
Products Services Applications Resource Center Ordering About Life Sciences Investor
microRNA Research
RNA Research
DNA Research
Custom Oligos
Other Reagents
RNA Isolation
Microarray Analysis
Real-time PCR
Northern Blotting
In Situ Hybridization
Functional Analysis
RNA Preparation
Microarray analysis
Real-time PCR
In Situ Hybridization
Antisense
SNP Detection
Microarray Analysis
In Situ Hybridization
LNA Phosphoramidites
AQ-link Products
A2 Quencher
RNA Isolation Services
microRNA Array Services
microRNA PCR Services
microRNA ISH Services
Isolation
Microarray Analysis
Northern Blotting
Real-time PCR
In Situ Hybridization
Functional Analysis
SNP Detection
RNA
microRNA
RNA
DNA
microRNA
microRNA
mRNA
microRNA
Other RNAs
DNA
microRNA
RNA
DNA
MicroRNA Research
RNA Research
Other reagents
Technology Base
Oligo design tools
Exiqon E-talk
Research Guide
Array Downloads
qPCR Data Analysis
Technical Literature and Manuals
Scientific Publications
Application Stories
Bioinformatics
Technical Literature and Manuals
Scientific Publications
Application Stories
Bioinformatics
Technical Literature and Manuals
Scientific Publications
Oligo modifications
LNA™
AQ-link
Order microRNA products
Order custom oligos
Distributors
General Information
Contact
Company profile
Sign up to Newsletter
Newsletter Back Issues
About Exiqon
Investor Relations
Media
Announcements
Financials
Guidelines for Incentive Pay
Corporate Governance
Investor Signup
Contact Us
History
Management
Board of Directors
Awards & Partnerships
Share Info
Calendar
Reports
Figures
Analysts
Presentations
Contact
Tal og fakta
Samarbejdspartnere
IR Policy
Articles of Association

About Exiqon

Exiqon operates in two business areas, Life Sciences and Diagnostics, which share:


  • One vision - pursue new scientific discoveries to improve healthcare
  • One focus - the promise of miRNA as biological markers
  • One technology platform - our proprietary LNA™ (Locked Nucleic Acid) detection technology.

Exiqon’s Life Sciences business and its diagnostics pipeline are helping drive the development towards new diagnostic capabilities and personalized medicine by helping scientists understand the biological function of miRNAs.


Exiqon Life Sciences is a leading one-stop supplier of products for miRNA research. Researchers around the world in academia, the biotechnology industry and recently the pharmaceutical industry, are using our research products to help better understand the biology of miRNAs which will contribute to making personalized medicine a reality.


Exiqon Diagnostics has a portfolio of new diagnostic and prognostic products in development that are based on miRNA as a biological marker. These products can help physicians treating cancer make the most appropriate treatment decisions. By allowing early detection of cancer or relevant stratification of patient populations, our diagnostic products aim to make it possible to increase the success rate of therapies and reduce the risk of adverse side effects and unnecessary costs.


Exiqon has is listed on the NASDAQ OMX in Copenhagen.


Lars Kongsbak
Chief Executive Officer
Business Areas

  Privacy   Sitemap   Legal